title: Aspirin therapy as primary prevention in hypertensive patients at Srinagarind hospital.
abstract: Aspirin is now a useful therapy for both primary and secondary prevention for cardiovascular events especially in diabetic patients. Hypertension is also one of the major atherosclerotic risk factors. The authors studied the rate of aspirin use as primary prevention in hypertensive cases at Srinagarind Hospital, Khon Kaen University. There were 164 of 231 hypertensive patients who were aged over 50 years old and met the criteria for aspirin therapy with 2003 ESHs guideline. Only 18.9% (31 of 164 cases) were prescribed aspirin. The most common dose of aspirin was 60 mg/day which was lower than the suggested dose. Within one-year follow up, there was no serious side effects of the aspirin such as upper gastrointestinal bleeding.
authors.affiliation: Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand. kittisak@kku.ac.th
authors.forename: Kittisak
authors.initials: K
authors.lastname: Sawanyawisuth
authors.forename: Panita
authors.initials: P
authors.lastname: Limpawattana
authors.forename: Sauwanan
authors.initials: S
authors.lastname: Bumrerraj
authors.forename: Akaphot
authors.initials: A
authors.lastname: Thongmee
authors.forename: Jakwida
authors.initials: J
authors.lastname: Kosakarn
authors.forename: Thanabat
authors.initials: T
authors.lastname: Choenrungroj
authors.forename: Prachaya
authors.initials: P
authors.lastname: Pradit
authors.forename: Patsathorn
authors.initials: P
authors.lastname: Naranunn
authors.forename: Sarunyaporn
authors.initials: S
authors.lastname: Punyamee
authors.forename: Amorn
authors.initials: A
authors.lastname: Premgamone
mesh_terms: D000368:Aged; D001241:Aspirin / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin